Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis mulling $1.5 mln-$5 mln price range for SMA gene therapy
Yahoo/Reuters
Wed, 04/24/19 - 12:02 pm
Tags:
Novartis, Zolgensma, gene therapy, drug pricing, spinal muscular atrophy
Novartis Poaches GSK Veteran as New Sandoz CEO
BioSpace
Wed, 04/24/19 - 11:48 am
Tags:
Novartis, Sandoz, generics, Pharma CEOs, Richard Saynor, GSK
Health-care earnings: ‘Medicare for all’ looms large
Marketwatch
Tue, 04/23/19 - 09:53 am
Tags:
earnings, Biogen, Novartis, Anthem, Boston Scientific
CAR-T Drugmaker Poseida Snags $142 Million in Financing Led by Novartis
BioSpace
Mon, 04/22/19 - 10:12 am
Tags:
Poseida Therapeutics, Novartis, CAR-T
Novartis' star gene therapy faces potential safety issue following a recent infant death in study
Endpoints
Sun, 04/21/19 - 12:23 am
Tags:
Novartis, Zolgensma, SMA
With FDA decision near, Novartis bolsters SMA gene therapy case
Biopharma Dive
Wed, 04/17/19 - 09:57 am
Tags:
Novartis, FDA, Zolgensma, spinal muscular atrophy
FDA accepts BLA for Novartis' AMD therapy
BioCentury
Mon, 04/15/19 - 11:31 pm
Tags:
Novartis, FDA, wet age-related macular degeneration, brolucizumab
Manufacturing problems persist for Aurobindo, U.S.' second-largest generics producer
Fierce Pharma
Tue, 04/9/19 - 10:18 pm
Tags:
Aurobindo, generics, Novartis, drug manufacturing
Novartis bribery investigation craters after Greek prosecutors clear 4 officials
Fierce Pharma
Tue, 04/9/19 - 06:52 pm
Tags:
Novartis, Greece, bribery
It’s a seller’s world in biotech M&A, and Novartis CEO Vas Narasimhan has his check book out and pen ready
Endpoints
Tue, 04/9/19 - 08:31 am
Tags:
Novartis, M&A, Alcon, Pharma CEOs, Vas Narasimhan
Novartis completes spin-out of Alcon eye unit
Pharmaforum
Tue, 04/9/19 - 08:21 am
Tags:
Novartis, Alcon, spinoffs, eye health
Scotland backs Aimovig for migraine after NICE says no
Pharmaforum
Tue, 04/9/19 - 08:20 am
Tags:
Scotland, NICE, migraines, Aimovig, Amgen, Novartis
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
Tags:
JNJ, Roche, Pfizer, Novartis, Merck, GSK, Sanofi, AbbVie, Bayer, Eli Lilly, Amgen, Bristol-Myers Squibb, Gilead Sciences, Teva Pharmaceutical, AstraZeneca
Lawsuit over migraine deal could be good for Amgen, analysts say
Marketwatch
Sat, 04/6/19 - 02:09 pm
Tags:
Novartis, Amgen, migraines, Aimovig
Amgen and Novartis file dueling lawsuits over their deal to market a migraine drug
Stat
Thu, 04/4/19 - 11:22 pm
Tags:
Novartis, Amgen, Aimovig, migraines
Novartis sues Amgen over migraine treatment Aimovig
Yahoo/Reuters
Thu, 04/4/19 - 12:04 pm
Tags:
Novartis, Amgen, Aimovig, migraines
Novartis CEO's $50 Billion of Deals Was Just the First Act
Yahoo/Bloomberg
Thu, 04/4/19 - 12:01 pm
Tags:
Novartis, M&A, Vas Narasimhan, Pharma CEOs
Novartis' SMA gene therapy would not be cost-effective if priced over $1.5M: ICER
Fierce Pharma
Thu, 04/4/19 - 11:54 am
Tags:
Novartis, ICER, drug pricing, Zolgensma, gene therapy, spinal muscular atrophy
Sandoz resubmission puts Amgen's Neulasta at further risk of competition
Biopharma Dive
Wed, 04/3/19 - 09:31 pm
Tags:
FDA, Novartis, biosimilars, Sandoz, Amgen, Neulasta
Another day, another $100M-plus biotech megaround as radiopharmaceuticals’ popularity grows
Endpoints
Tue, 04/2/19 - 12:20 pm
Tags:
Fusion Pharmaceuticals, radiopharmaceuticals, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.